Articles Vol. 67 No. 3 31/03/2026

INITIAL OUTCOME OF WARM COMPRESSES THERAPY FOR MEIBOMIAN GLAND DYSFUNCTION

Tran Thi Huong Tra1,2, Nguyen Thi Thu Thuy1,2, Tran Thuy Trang1,2, Dang Thi Minh Tue1,2
1 Cornea Department, National Eye Hospital.
2 Khoa Giác mạc, Bệnh viện Mắt Trung ương.
DOI: 10.52163/yhc.v67i3.4653
13 Views
3 Downloads
Keywords
Meibomian gland dysfunction, warm eyelid compress.
Abstract

Introduction: Meibomian gland dysfunction (MGD) is the leading cause of dry eye disease due to abnormalities in the lipid layer of the tear film. Warm eyelid compress using the warm patch, inexpensive, and easily applicable treatment method.

Aim of Study: To evaluate the efficacy of warm eyelid compresses in improving symptoms, clinical signs, and Meibomian gland function in patients with MGD.

Methods: The study was conducted on 68 eyes of 34 patients diagnosed with MGD, treated with warm eyelid compresses for 8 weeks. Assessment parameters included the Ocular Surface Disease Index (OSDI), tear break-up time (TBUT).

Results: The mean age was 56.8 ± 14 years. Females accounted for the majority with 91.2%. After intervention, patients reported reduced ocular discomfort. Mean OSDI scores decreased (47.63 ± 17.72; 38.88 ± 13.62; 33.89 ± 13.29), while TBUT increased (4.59 ± 3.51; 5.16 ± 2.2; 5.5 ± 2.3) at 4 and 8 weeks. No serious adverse effects were recorded.

Conclusion: Warm eyelid compress is a safe, effective, and easy-to-apply method in the treatment of Meibomian gland dysfunction. The study results support its routine use as a fundamental therapeutic option for patients with MGD.

References
[1]
Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017;15(3):334-365. doi:10.1016/j.jtos.2017.05.003 Google Scholar
[2]
Wang DH, Guo H, Xu W, Liu XQ. Efficacy and safety of the disposable eyelid warming masks in the treatment of dry eye disease due to Meibomian gland dysfunction. BMC Ophthalmol. 2024;24:376. doi:10.1186/s12886-024-03642-z Google Scholar
[3]
Ballesteros-Sánchez A, Rocha-de-Lossada C, Sánchez-González JM. Efficacy of eyelid warming devices as first-step treatment in meibomian gland dysfunction: A systematic review with meta-analysis. Ocul Surf. 2025;37:33-46. doi:10.1016/j.jtos.2025.02.008 Google Scholar
[4]
Mencucci R, Mercuri S, Cennamo M, Morelli A, Favuzza E. Efficacy of vector thermal pulsation treatment in reducing postcataract surgery dry eye disease in patients affected by meibomian gland dysfunction. J Cataract Refract Surg. 2023;49(4):423. doi:10.1097/j.jcrs.0000000000001124 Google Scholar
[5]
Liu W, Lin T, Gong L. Meibomian gland dysfunction patients benefit in ocular parameters and tear chemokines after thermal pulsation treatment. Int J Med Sci. 2023;20(1):11-22. doi:10.7150/ijms.76603 Google Scholar
[6]
Sun CC, Lee CY, Hwang YS, Michihito I, Tagami K, Hsiao CH. Effect of warming eyelids on tear film stability and quality of life in visual display terminal users: a randomized controlled trial. Sci Rep. 2020;10(1):16919. doi:10.1038/s41598-020-73779-6 Google Scholar
[7]
Wang MTM, Muntz A, Lim J, et al. Ageing and the natural history of dry eye disease: A prospective registry-based cross-sectional study. Ocul Surf. 2020;18(4):736-741. doi:10.1016/j.jtos.2020.07.003 Google Scholar
[8]
The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction - PubMed. Accessed February 5, 2026. https://pubmed.ncbi.nlm.nih.gov/21450919/ Google Scholar
[9]
Arita R, Fukuoka S, Morishige N. Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction. Ocul Surf. 2019;17(1):104-110. doi:10.1016/j.jtos.2018.11.004 Google Scholar
[10]
Blackie CA, Murakami D, Donnenfeld E, Oliff HS. Vectored Thermal Pulsation as a Treatment for Meibomian Gland Dysfunction: A Review Spanning 15 Years. Ophthalmol Ther. 2024;13(8):2083-2123. doi:10.1007/s40123-024-00976-1 Google Scholar